Last 12 months
Inside the activity.
3 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 3 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 10, 2018 Filed May 14, 2018 20:32 UTC |
McEvoy Timothy GSr. VP, Gen. Counsel & Sec.
|
SaleCommon Stock | 1,500 | $66.45 | $99,675.00 |
DisclosureSEC source: 0001209191-18-029851 · doc4.xml · nonDerivative · entry 1 McEvoy Timothy G · CIK 0001389013 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,331 Read SEC document |
| May 09, 2018 Filed May 9, 2018 21:42 UTC |
Smyth DeclanPres., Advanced Surgical, Orth
|
SaleCommon Stock | 2,913 | $66.49 | $193,685.37 |
DisclosureSEC source: 0001209191-18-028959 · doc4.xml · nonDerivative · entry 1 Smyth Declan · CIK 0001657037 · Pres., Advanced Surgical, Orth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,766 Read SEC document |
| May 07, 2018 Filed May 8, 2018 21:40 UTC |
Spencer Michael LChief Ethics & Compliance Of
|
SaleCommon Stock | 100 | $65.00 | $6,500.00 |
DisclosureSEC source: 0001209191-18-028670 · doc4.xml · nonDerivative · entry 1 Spencer Michael L · CIK 0001706106 · Chief Ethics & Compliance Of 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,979 Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:35 UTC |
Spencer Michael LChief Ethics & Compliance Of
|
GrantRestricted Stock Units · Derivative | 1,782 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019317 · doc4.xml · derivative · entry 3 Spencer Michael L · CIK 0001706106 · Chief Ethics & Compliance Of 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,782 Underlying: Common · 1,782 shares Expires not disclosed F2 · kind: Represent the portion of a PRSU award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance conditions were determined to have been met as of March 9, 2018. The PRSUs are scheduled to vest in two approximately equal installments on December 28, 2018 and January 3, 2020, provided the reporting person is employed by the Issuer on the vesting date. F2 · derivative.exercise_date: Represent the portion of a PRSU award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance conditions were determined to have been met as of March 9, 2018. The PRSUs are scheduled to vest in two approximately equal installments on December 28, 2018 and January 3, 2020, provided the reporting person is employed by the Issuer on the vesting date. F2 · derivative.expiration_date: Represent the portion of a PRSU award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance conditions were determined to have been met as of March 9, 2018. The PRSUs are scheduled to vest in two approximately equal installments on December 28, 2018 and January 3, 2020, provided the reporting person is employed by the Issuer on the vesting date. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:35 UTC |
Spencer Michael LChief Ethics & Compliance Of
|
Tax withholdingCommon Stock | 1,000 | $53.80 | $53,800.00 |
DisclosureSEC source: 0001209191-18-019317 · doc4.xml · nonDerivative · entry 2 Spencer Michael L · CIK 0001706106 · Chief Ethics & Compliance Of 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,079 Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:35 UTC |
Spencer Michael LChief Ethics & Compliance Of
|
GrantCommon Stock | 3,924 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019317 · doc4.xml · nonDerivative · entry 1 Spencer Michael L · CIK 0001706106 · Chief Ethics & Compliance Of 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,079 F1 · kind: Represent the portion of a performance-based restricted stock unit ("PRSU") award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance and service conditions were determined to have been met as of March 9, 2018. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:33 UTC |
Smyth DeclanPres., Advanced Surgical, Orth
|
GrantRestricted Stock Units · Derivative | 3,961 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019314 · doc4.xml · derivative · entry 3 Smyth Declan · CIK 0001657037 · Pres., Advanced Surgical, Orth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,961 Underlying: Common · 3,961 shares Expires not disclosed F2 · kind: Represent the portion of a PRSU award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance conditions were determined to have been met as of March 9, 2018. The PRSUs are scheduled to vest in two approximately equal installments on December 28, 2018 and January 3, 2020, provided the reporting person is employed by the Issuer on the vesting date. F2 · derivative.exercise_date: Represent the portion of a PRSU award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance conditions were determined to have been met as of March 9, 2018. The PRSUs are scheduled to vest in two approximately equal installments on December 28, 2018 and January 3, 2020, provided the reporting person is employed by the Issuer on the vesting date. F2 · derivative.expiration_date: Represent the portion of a PRSU award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance conditions were determined to have been met as of March 9, 2018. The PRSUs are scheduled to vest in two approximately equal installments on December 28, 2018 and January 3, 2020, provided the reporting person is employed by the Issuer on the vesting date. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:33 UTC |
Smyth DeclanPres., Advanced Surgical, Orth
|
Tax withholdingCommon Stock | 1,826 | $53.80 | $98,238.80 |
DisclosureSEC source: 0001209191-18-019314 · doc4.xml · nonDerivative · entry 2 Smyth Declan · CIK 0001657037 · Pres., Advanced Surgical, Orth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,679 Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:33 UTC |
Smyth DeclanPres., Advanced Surgical, Orth
|
GrantCommon Stock | 6,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019314 · doc4.xml · nonDerivative · entry 1 Smyth Declan · CIK 0001657037 · Pres., Advanced Surgical, Orth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,505 F1 · kind: Represent the portion of a performance-based restricted stock unit ("PRSU") award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance and service conditions were determined to have been met as of March 9, 2018. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:29 UTC |
Haire Gary JEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 1,190 | $53.80 | $64,022.00 |
DisclosureSEC source: 0001209191-18-019307 · doc4.xml · nonDerivative · entry 2 Haire Gary J · CIK 0001705183 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,529 Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:29 UTC |
Haire Gary JEVP & Chief Financial Officer
|
GrantCommon Stock | 4,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019307 · doc4.xml · nonDerivative · entry 1 Haire Gary J · CIK 0001705183 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,719 F1 · kind: Represent the portion of a performance-based restricted stock unit ("PRSU") award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance and service conditions were determined to have been met as of March 9, 2018. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:31 UTC |
McEvoy Timothy GSr. VP, Gen. Counsel & Sec.
|
GrantRestricted Stock Units · Derivative | 3,565 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019311 · doc4.xml · derivative · entry 4 McEvoy Timothy G · CIK 0001389013 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,565 Underlying: Common · 3,565 shares Expires not disclosed F2 · kind: Represent the portion of a PRSU award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance conditions were determined to have been met as of March 9, 2018. The PRSUs are scheduled to vest in two approximately equal installments on December 28, 2018 and January 3, 2020, provided the reporting person is employed by the Issuer on the vesting date. F2 · derivative.exercise_date: Represent the portion of a PRSU award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance conditions were determined to have been met as of March 9, 2018. The PRSUs are scheduled to vest in two approximately equal installments on December 28, 2018 and January 3, 2020, provided the reporting person is employed by the Issuer on the vesting date. F2 · derivative.expiration_date: Represent the portion of a PRSU award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance conditions were determined to have been met as of March 9, 2018. The PRSUs are scheduled to vest in two approximately equal installments on December 28, 2018 and January 3, 2020, provided the reporting person is employed by the Issuer on the vesting date. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:31 UTC |
McEvoy Timothy GSr. VP, Gen. Counsel & Sec.
|
Tax withholdingCommon Stock | 1,522 | $53.80 | $81,883.60 |
DisclosureSEC source: 0001209191-18-019311 · doc4.xml · nonDerivative · entry 2 McEvoy Timothy G · CIK 0001389013 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,831 Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:31 UTC |
McEvoy Timothy GSr. VP, Gen. Counsel & Sec.
|
GrantCommon Stock | 4,511 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019311 · doc4.xml · nonDerivative · entry 1 McEvoy Timothy G · CIK 0001389013 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,353 F1 · kind: Represent the portion of a performance-based restricted stock unit ("PRSU") award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance and service conditions were determined to have been met as of March 9, 2018. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:27 UTC |
Gonzalez Jose AntonioPresident, CRM & Neuro
|
GrantRestricted Stock Units · Derivative | 3,961 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019302 · doc4.xml · derivative · entry 4 Gonzalez Jose Antonio · CIK 0001657033 · President, CRM & Neuro 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,961 Underlying: Common · 3,961 shares Expires not disclosed F2 · kind: Represent the portion of a PRSU award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance conditions were determined to have been met as of March 9, 2018. The PRSUs are scheduled to vest in two approximately equal installments on December 28, 2018 and January 3, 2020, provided the reporting person is employed by the Issuer on the vesting date. F2 · derivative.exercise_date: Represent the portion of a PRSU award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance conditions were determined to have been met as of March 9, 2018. The PRSUs are scheduled to vest in two approximately equal installments on December 28, 2018 and January 3, 2020, provided the reporting person is employed by the Issuer on the vesting date. F2 · derivative.expiration_date: Represent the portion of a PRSU award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance conditions were determined to have been met as of March 9, 2018. The PRSUs are scheduled to vest in two approximately equal installments on December 28, 2018 and January 3, 2020, provided the reporting person is employed by the Issuer on the vesting date. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:27 UTC |
Gonzalez Jose AntonioPresident, CRM & Neuro
|
Tax withholdingCommon Stock | 1,401 | $53.80 | $75,373.80 |
DisclosureSEC source: 0001209191-18-019302 · doc4.xml · nonDerivative · entry 2 Gonzalez Jose Antonio · CIK 0001657033 · President, CRM & Neuro 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,657 Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:27 UTC |
Gonzalez Jose AntonioPresident, CRM & Neuro
|
GrantCommon Stock | 5,684 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019302 · doc4.xml · nonDerivative · entry 1 Gonzalez Jose Antonio · CIK 0001657033 · President, CRM & Neuro 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,058 F1 · kind: Represent the portion of a performance-based restricted stock unit ("PRSU") award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance and service conditions were determined to have been met as of March 9, 2018. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:24 UTC |
Friedman JeremyEVP, COO
|
Tax withholdingCommon Stock | 3,213 | $53.80 | $172,859.40 |
DisclosureSEC source: 0001209191-18-019297 · doc4.xml · nonDerivative · entry 2 Friedman Jeremy · CIK 0001657040 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,693 Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:24 UTC |
Friedman JeremyEVP, COO
|
GrantCommon Stock | 13,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019297 · doc4.xml · nonDerivative · entry 1 Friedman Jeremy · CIK 0001657040 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,906 F1 · kind: Represent the portion of a performance-based restricted stock unit ("PRSU") award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance and service conditions were determined to have been met as of March 9, 2018. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:22 UTC |
Flanagan Joseph FEVP, Quality & Regulatory Affa
|
GrantRestricted Stock Units · Derivative | 2,297 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019292 · doc4.xml · derivative · entry 3 Flanagan Joseph F · CIK 0001706095 · EVP, Quality & Regulatory Affa 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,297 Underlying: Common · 2,297 shares Expires not disclosed F2 · kind: Represent the portion of a PRSU award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance conditions were determined to have been met as of March 9, 2018. The PRSUs are scheduled to vest in two approximately equal installments on December 28, 2018 and January 3, 2020, provided the reporting person is employed by the Issuer on the vesting date. F2 · derivative.exercise_date: Represent the portion of a PRSU award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance conditions were determined to have been met as of March 9, 2018. The PRSUs are scheduled to vest in two approximately equal installments on December 28, 2018 and January 3, 2020, provided the reporting person is employed by the Issuer on the vesting date. F2 · derivative.expiration_date: Represent the portion of a PRSU award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance conditions were determined to have been met as of March 9, 2018. The PRSUs are scheduled to vest in two approximately equal installments on December 28, 2018 and January 3, 2020, provided the reporting person is employed by the Issuer on the vesting date. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:22 UTC |
Flanagan Joseph FEVP, Quality & Regulatory Affa
|
Tax withholdingCommon Stock | 1,221 | $53.80 | $65,689.80 |
DisclosureSEC source: 0001209191-18-019292 · doc4.xml · nonDerivative · entry 2 Flanagan Joseph F · CIK 0001706095 · EVP, Quality & Regulatory Affa 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,014 Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:22 UTC |
Flanagan Joseph FEVP, Quality & Regulatory Affa
|
GrantCommon Stock | 3,992 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019292 · doc4.xml · nonDerivative · entry 1 Flanagan Joseph F · CIK 0001706095 · EVP, Quality & Regulatory Affa 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,235 F1 · kind: Represent the portion of a performance-based restricted stock unit ("PRSU") award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance and service conditions were determined to have been met as of March 9, 2018. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:21 UTC |
Dziedzic Joseph WDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 9,194 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019286 · doc4.xml · derivative · entry 3 Dziedzic Joseph W · CIK 0001468603 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,194 Underlying: Common · 9,194 shares Expires not disclosed F2 · kind: Represent the portion of a PRSU award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance conditions were determined to have been met as of March 9, 2018. The PRSUs are scheduled to vest in two approximately equal installments on December 28, 2018 and January 3, 2020, provided the reporting person is employed by the Issuer on the vesting date. F2 · derivative.exercise_date: Represent the portion of a PRSU award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance conditions were determined to have been met as of March 9, 2018. The PRSUs are scheduled to vest in two approximately equal installments on December 28, 2018 and January 3, 2020, provided the reporting person is employed by the Issuer on the vesting date. F2 · derivative.expiration_date: Represent the portion of a PRSU award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance conditions were determined to have been met as of March 9, 2018. The PRSUs are scheduled to vest in two approximately equal installments on December 28, 2018 and January 3, 2020, provided the reporting person is employed by the Issuer on the vesting date. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:21 UTC |
Dziedzic Joseph WDirector · President & CEO
|
Tax withholdingCommon Stock | 2,180 | $53.80 | $117,284.00 |
DisclosureSEC source: 0001209191-18-019286 · doc4.xml · nonDerivative · entry 2 Dziedzic Joseph W · CIK 0001468603 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,123 Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:21 UTC |
Dziedzic Joseph WDirector · President & CEO
|
GrantCommon Stock | 8,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019286 · doc4.xml · nonDerivative · entry 1 Dziedzic Joseph W · CIK 0001468603 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,303 F1 · kind: Represent the portion of a performance-based restricted stock unit ("PRSU") award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance and service conditions were determined to have been met as of March 9, 2018. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:18 UTC |
Bolt Jennifer MPresident, Electrochem
|
GrantRestricted Stock Units · Derivative | 1,584 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019279 · doc4.xml · derivative · entry 4 Bolt Jennifer M · CIK 0001657244 · President, Electrochem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,584 Underlying: Common · 1,584 shares Expires not disclosed F2 · kind: Represent the portion of a PRSU award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance conditions were determined to have been met as of March 9, 2018. The PRSUs are scheduled to vest in two approximately equal installments on December 28, 2018 and January 3, 2020, provided the reporting person is employed by the Issuer on the vesting date. F2 · derivative.exercise_date: Represent the portion of a PRSU award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance conditions were determined to have been met as of March 9, 2018. The PRSUs are scheduled to vest in two approximately equal installments on December 28, 2018 and January 3, 2020, provided the reporting person is employed by the Issuer on the vesting date. F2 · derivative.expiration_date: Represent the portion of a PRSU award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance conditions were determined to have been met as of March 9, 2018. The PRSUs are scheduled to vest in two approximately equal installments on December 28, 2018 and January 3, 2020, provided the reporting person is employed by the Issuer on the vesting date. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:18 UTC |
Bolt Jennifer MPresident, Electrochem
|
Tax withholdingCommon Stock | 1,085 | $53.80 | $58,373.00 |
DisclosureSEC source: 0001209191-18-019279 · doc4.xml · nonDerivative · entry 2 Bolt Jennifer M · CIK 0001657244 · President, Electrochem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,292 Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:18 UTC |
Bolt Jennifer MPresident, Electrochem
|
GrantCommon Stock | 3,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019279 · doc4.xml · nonDerivative · entry 1 Bolt Jennifer M · CIK 0001657244 · President, Electrochem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,377 F1 · kind: Represent the portion of a performance-based restricted stock unit ("PRSU") award made on February 6, 2017 that was determined to be earned based on performance for the period ending December 29, 2017. The established performance and service conditions were determined to have been met as of March 9, 2018. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 19:01 UTC |
Khales PaymanPresident, C&V
|
GrantRestricted Stock Units · Derivative | 1,886 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-018789 · doc4.xml · derivative · entry 1 Khales Payman · CIK 0001731729 · President, C&V 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,886 Underlying: Common · 1,886 shares Expires not disclosed F1 · derivative.exercise_date: Grant of restricted stock units that vest in three equal annual installments on the last day of each fiscal year beginning in fiscal year 2018. F1 · derivative.expiration_date: Grant of restricted stock units that vest in three equal annual installments on the last day of each fiscal year beginning in fiscal year 2018. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 21:10 UTC |
Hinrichs James F.Director
|
GrantNon-Qualified Stock Options · Derivative | 7,648 | $0.00 Strike: $44.60 | $0.00 |
DisclosureSEC source: 0001209191-18-009956 · doc4.xml · derivative · entry 3 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,648 Underlying: Common · 7,648 shares Expires 2028-02-12 F3 · derivative.exercise_date: Grant of non-qualified stock options that vest in three equal annual installments on the last day of each fiscal year beginning in fiscal year 2018. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 21:10 UTC |
Hinrichs James F.Director
|
GrantNon-Qualified Stock Options · Derivative | 1,955 | $0.00 Strike: $44.60 | $0.00 |
DisclosureSEC source: 0001209191-18-009956 · doc4.xml · derivative · entry 2 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,955 Underlying: Common · 1,955 shares Expires 2028-02-12 F2 · derivative.exercise_date: Grant of non-qualified stock options of which 355 options vest immediately and the remaining options will vest in three equal installments on April 2, 2018, July 2, 2018 and October 1, 2018. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 21:10 UTC |
Hinrichs James F.Director
|
GrantCommon Stock | 1,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-009956 · doc4.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,925 F1 · shares: Grant of restricted stock of which 350 shares vest immediately and the remaining shares will vest in three equal installments on April 2, 2018, July 2, 2018 and October 1, 2018. Read SEC document |
| February 05, 2018 Filed Feb 6, 2018 16:42 UTC |
Thomas Tommy PVP, Corporate Controller
|
GrantRestricted Stock Units · Derivative | 1,067 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-007781 · doc4.xml · derivative · entry 1 Thomas Tommy P · CIK 0001730071 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,067 Underlying: Common · 1,067 shares Expires not disclosed F1 · derivative.exercise_date: Grant of restricted stock units that vest in three equal annual installments on the last day of each fiscal year beginning in 2018. F1 · derivative.expiration_date: Grant of restricted stock units that vest in three equal annual installments on the last day of each fiscal year beginning in 2018. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 21:24 UTC |
Bolt Jennifer MPresident, Electrochem
|
GrantRestricted Stock Units · Derivative | 1,661 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006870 · doc4.xml · derivative · entry 3 Bolt Jennifer M · CIK 0001657244 · President, Electrochem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,661 Underlying: Common · 1,661 shares Expires not disclosed F1 · derivative.exercise_date: Grant of restricted stock units that vest in three equal annual installments on the last day of each fiscal year beginning 2018. F1 · derivative.expiration_date: Grant of restricted stock units that vest in three equal annual installments on the last day of each fiscal year beginning 2018. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 21:13 UTC |
Gonzalez Jose AntonioPresident, CRM & Neuro
|
GrantRestricted Stock Units · Derivative | 3,323 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006825 · doc4.xml · derivative · entry 3 Gonzalez Jose Antonio · CIK 0001657033 · President, CRM & Neuro 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,323 Underlying: Common · 3,323 shares Expires not disclosed F1 · derivative.exercise_date: Grant of restricted stock units that vest in three equal annual installments on the last day of each fiscal year beginning 2018. F1 · derivative.expiration_date: Grant of restricted stock units that vest in three equal annual installments on the last day of each fiscal year beginning 2018. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 21:20 UTC |
Dziedzic Joseph WDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 22,033 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006852 · doc4.xml · derivative · entry 2 Dziedzic Joseph W · CIK 0001468603 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,033 Underlying: Common · 22,033 shares Expires not disclosed F1 · derivative.exercise_date: Grant of restricted stock units that vest in three equal annual installments on the last day of each fiscal year beginning in fiscal year 2018. F1 · derivative.expiration_date: Grant of restricted stock units that vest in three equal annual installments on the last day of each fiscal year beginning in fiscal year 2018. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 21:17 UTC |
Flanagan Joseph FEVP, Quality & Regulatory Affa
|
GrantRestricted Stock Units · Derivative | 2,060 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006844 · doc4.xml · derivative · entry 2 Flanagan Joseph F · CIK 0001706095 · EVP, Quality & Regulatory Affa 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,060 Underlying: Common · 2,060 shares Expires not disclosed F1 · derivative.exercise_date: Grant of restricted stock units that vest in three equal annual installments on the last day of each fiscal year beginning in fiscal year 2018. F1 · derivative.expiration_date: Grant of restricted stock units that vest in three equal annual installments on the last day of each fiscal year beginning in fiscal year 2018. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 21:10 UTC |
Haire Gary JEVP & Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 4,652 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006815 · doc4.xml · derivative · entry 2 Haire Gary J · CIK 0001705183 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,652 Underlying: Common · 4,652 shares Expires not disclosed F1 · derivative.exercise_date: Grant of restricted stock units that vest in three equal annual installments on the last day of each fiscal year beginning in fiscal year 2018. F1 · derivative.expiration_date: Grant of restricted stock units that vest in three equal annual installments on the last day of each fiscal year beginning in fiscal year 2018. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 21:03 UTC |
Spencer Michael LChief Ethics & Compliance Of
|
GrantRestricted Stock Units · Derivative | 1,495 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006794 · doc4.xml · derivative · entry 2 Spencer Michael L · CIK 0001706106 · Chief Ethics & Compliance Of 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,495 Underlying: Common · 1,495 shares Expires not disclosed F1 · derivative.exercise_date: Grant of restricted stock units that vest in three equal annual installments on the last day of each fiscal year beginning in fiscal year 2018. F1 · derivative.expiration_date: Grant of restricted stock units that vest in three equal annual installments on the last day of each fiscal year beginning in fiscal year 2018. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 21:06 UTC |
Smyth DeclanPres., Advanced Surgical, Orth
|
GrantRestricted Stock Units · Derivative | 3,323 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006798 · doc4.xml · derivative · entry 2 Smyth Declan · CIK 0001657037 · Pres., Advanced Surgical, Orth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,323 Underlying: Common · 3,323 shares Expires not disclosed F1 · derivative.exercise_date: Grant of restricted stock units that vest in three equal annual installments on the last day of each fiscal year beginning in fiscal year 2018. F1 · derivative.expiration_date: Grant of restricted stock units that vest in three equal annual installments on the last day of each fiscal year beginning in fiscal year 2018. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 21:08 UTC |
McEvoy Timothy GSr. VP, Gen. Counsel & Sec.
|
GrantRestricted Stock Units · Derivative | 1,994 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006803 · doc4.xml · derivative · entry 3 McEvoy Timothy G · CIK 0001389013 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,994 Underlying: Common · 1,994 shares Expires not disclosed F1 · derivative.exercise_date: Grant of restricted stock units that vest in three equal annual installments on the last day of each fiscal year beginning 2018. F1 · derivative.expiration_date: Grant of restricted stock units that vest in three equal annual installments on the last day of each fiscal year beginning 2018. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 21:00 UTC |
Thor Kirk KChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 1,595 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006787 · doc4.xml · derivative · entry 1 Thor Kirk K · CIK 0001726955 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,595 Underlying: Common · 1,595 shares Expires not disclosed F1 · derivative.exercise_date: Grant of restricted stock units that vest in three equal annual installments on the last day of each fiscal year beginning 2018. F1 · derivative.expiration_date: Grant of restricted stock units that vest in three equal annual installments on the last day of each fiscal year beginning 2018. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:19 UTC |
Spencer Michael LChief Ethics & Compliance Of
|
SaleCommon Stock | 308 | $44.89 | $13,826.12 |
DisclosureSEC source: 0001209191-18-002458 · doc4.xml · nonDerivative · entry 1 Spencer Michael L · CIK 0001706106 · Chief Ethics & Compliance Of 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,155 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs reported on a Form 4 filed on January 3, 2018. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:10 UTC |
McEvoy Timothy GSr. VP, Gen. Counsel & Sec.
|
SaleCommon Stock | 562 | $44.89 | $25,228.18 |
DisclosureSEC source: 0001209191-18-002444 · doc4.xml · nonDerivative · entry 1 McEvoy Timothy G · CIK 0001389013 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,842 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs reported on a Form 4 filed on January 3, 2018. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:13 UTC |
Smyth DeclanPres., Advanced Surgical, Orth
|
SaleCommon Stock | 1,112 | $44.89 | $49,917.68 |
DisclosureSEC source: 0001209191-18-002450 · doc4.xml · nonDerivative · entry 1 Smyth Declan · CIK 0001657037 · Pres., Advanced Surgical, Orth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,370 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs reported on a Form 4 filed on January 3, 2018. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:07 UTC |
MAZZA THOMAS JVP, Corporate Controller
|
SaleCommon Stock | 77 | $44.89 | $3,456.53 |
DisclosureSEC source: 0001209191-18-002437 · doc4.xml · nonDerivative · entry 1 MAZZA THOMAS J · CIK 0001221436 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,123 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs reported on a Form 4 filed on January 3, 2018. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:03 UTC |
Haire Gary JEVP & Chief Financial Officer
|
SaleCommon Stock | 731 | $44.89 | $32,814.59 |
DisclosureSEC source: 0001209191-18-002434 · doc4.xml · nonDerivative · entry 1 Haire Gary J · CIK 0001705183 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,911 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs reported on a Form 4 filed on January 3, 2018. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 20:58 UTC |
Gonzalez Jose AntonioPresident, CRM & Neuro
|
SaleCommon Stock | 463 | $44.89 | $20,784.07 |
DisclosureSEC source: 0001209191-18-002425 · doc4.xml · nonDerivative · entry 1 Gonzalez Jose Antonio · CIK 0001657033 · President, CRM & Neuro 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,374 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs reported on a Form 4 filed on January 3, 2018. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 20:54 UTC |
Friedman JeremyEVP, COO
|
SaleCommon Stock | 8,163 | $44.89 | $366,437.07 |
DisclosureSEC source: 0001209191-18-002418 · doc4.xml · nonDerivative · entry 1 Friedman Jeremy · CIK 0001657040 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,673 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs reported on a Form 4 filed on January 3, 2018. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 20:51 UTC |
Flanagan Joseph FEVP, Quality & Regulatory Affa
|
SaleCommon Stock | 799 | $44.89 | $35,867.11 |
DisclosureSEC source: 0001209191-18-002411 · doc4.xml · nonDerivative · entry 1 Flanagan Joseph F · CIK 0001706095 · EVP, Quality & Regulatory Affa 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,243 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs reported on a Form 4 filed on January 3, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.